Subcutaneous Sustained-Release of Poly-Arginine Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease

Journals Menu

Follow SCIRP

ISSN Print: 2169-2459
ISSN Online: 2169-2467
www.scirp.org/journal/aad
E-mail: aad@scirp.org

"Subcutaneous Sustained-Release of Poly-Arginine Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease"
written by Gennadiy Fonar, Baruh Polis, Tomer Meirson, Alexander Maltsev, Abraham O. Samson,
published by Advances in Alzheimer's Disease, Vol.7 No.4, 2018

has been cited by the following article(s):

[1]	Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer's Disease Mice
	2021

[2]	Arginine and arginine-rich peptides as modulators of protein aggregation and cytotoxicity associated with Alzheimer's disease
	Frontiers in Molecular Neuroscience, 2021

[3]	Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action
	2020

[4]	In vitro cellular uptake and neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: critical role of arginine guanidinium head groups …
	2019

[5]	Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke Model
	2019

[1]	Neurobiochemical characteristics of arginine-rich peptides explain their potential therapeutic efficacy in neurodegenerative diseases Neuropeptides, 2023 DOI:10.1016/j.npep.2023.102356

[2]	Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice Molecular Neurobiology, 2021 DOI:10.1007/s12035-020-02270-0

[3]	Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer’s Disease Frontiers in Molecular Neuroscience, 2021 DOI:10.3389/fnmol.2021.759729

[4]	Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action Frontiers in Neurology, 2020 DOI:10.3389/fneur.2020.00108

[5]	In vitro cellular uptake and neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: critical role of arginine guanidinium head groups for neuroprotection Molecular and Cellular Biochemistry, 2019 DOI:10.1007/s11010-019-03646-0

[6]	Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke Model Neurotherapeutics, 2019 DOI:10.1007/s13311-019-00809-1

Follow SCIRP